Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $522.43 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $255.26 | 11 | $0 (2024) |
| Novo Nordisk Inc | $64.06 | 4 | $0 (2024) |
| Amgen Inc. | $42.25 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $35.38 | 2 | $0 (2024) |
| Lilly USA, LLC | $29.07 | 2 | $0 (2024) |
| Boston Scientific Corporation | $24.74 | 1 | $0 (2024) |
| PFIZER INC. | $23.51 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $18.56 | 1 | $0 (2024) |
| Averitas Pharma Inc. | $16.38 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $13.22 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $361.80 | 19 | ABBVIE INC. ($173.77) |
| 2023 | $160.63 | 8 | AbbVie Inc. ($81.49) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: General - EP_EP | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardio-renal | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: PAIN | ||||||
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Inflammation | ||||||
| 02/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Obesity | ||||||
| 02/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: VACCINE | ||||||
| 01/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Diabetes | ||||||
| 01/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Obesity | ||||||
| 11/15/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardio-renal | ||||||
| 10/11/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 102 | 138 | $52,954 | $12,684 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 97 | $37,054 | $9,492 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $10,500 | $1,924 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $5,400 | $1,269 | 23.5% |
About Dr. Celeste Vickery, D.O
Dr. Celeste Vickery, D.O is a Family Medicine healthcare provider based in Orange City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2020. The National Provider Identifier (NPI) number assigned to this provider is 1780211821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Celeste Vickery, D.O has received a total of $522.43 in payments from pharmaceutical and medical device companies, with $361.80 received in 2024. These payments were reported across 27 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($522.43).
As a Medicare-enrolled provider, Vickery has provided services to 102 Medicare beneficiaries, totaling 138 services with total Medicare billing of $12,684. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Orange City, FL
- Active Since 03/26/2020
- Last Updated 09/19/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780211821
Products in Payments
- QULIPTA (Drug) $176.95
- UBRELVY (Drug) $66.95
- Otezla (Drug) $42.25
- Kerendia (Drug) $35.38
- Wegovy (Drug) $33.15
- Rybelsus (Drug) $30.91
- NURTEC ODT (Drug) $23.51
- FARXIGA (Drug) $18.56
- QUTENZA (Drug) $16.38
- JARDIANCE (Drug) $14.59
- MOUNJARO (Drug) $14.48
- GARDASIL (Biological) $13.22
- VRAYLAR (Drug) $11.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Orange City
Jose Rosales, Md, MD
Family Medicine — Payments: $57,202
Dr. Douglas Witter, M.d, M.D
Family Medicine — Payments: $5,575
Dr. Arletty Smith, Md, MD
Family Medicine — Payments: $2,683
Dr. Shazia Ahmed, M.d, M.D
Family Medicine — Payments: $883.38
Krista Brinkerhoff
Family Medicine — Payments: $603.29
Josette Romain, M.d, M.D
Family Medicine — Payments: $564.37